Index RUT
P/E 132.36
EPS (ttm) 0.31
Insider Own 0.78%
Shs Outstand 48.84M
Perf Week -4.35%
Market Cap 2.01B
Forward P/E 51.12
EPS next Y 0.80
Insider Trans 174.36%
Shs Float 48.75M
Perf Month -12.82%
Income 15.30M
PEG 4.41
EPS next Q 0.22
Inst Own 98.02%
Short Float 8.72%
Perf Quarter 25.28%
Sales 326.24M
P/S 6.17
EPS this Y -36.63%
Inst Trans 2.07%
Short Ratio 6.31
Perf Half Y 20.77%
Book/sh 8.00
P/B 5.12
EPS next Y 25.13%
ROA 3.36%
Short Interest 4.25M
Perf Year -30.98%
Cash/sh 4.99
P/C 8.20
EPS next 5Y 30.00%
ROE 4.18%
52W Range 26.66 - 60.79
Perf YTD 31.18%
Dividend Est. -
P/FCF 96.33
EPS past 5Y 31.51%
ROI 3.61%
52W High -32.65%
Beta 0.65
Dividend TTM -
Quick Ratio 5.22
Sales past 5Y 21.55%
Gross Margin 78.51%
52W Low 53.59%
ATR (14) 1.79
Dividend Ex-Date -
Current Ratio 5.84
EPS Y/Y TTM -52.52%
Oper. Margin 7.05%
RSI (14) 38.13
Volatility 3.03% 4.07%
Employees 1115
Debt/Eq 0.09
Sales Y/Y TTM 10.70%
Profit Margin 4.69%
Recom 1.92
Target Price 52.31
Option/Short Yes / Yes
LT Debt/Eq 0.08
EPS Q/Q -224.64%
Payout 0.00%
Rel Volume 0.37
Prev Close 41.16
Sales Surprise 2.68%
EPS Surprise 74.84%
Sales Q/Q 5.21%
Earnings May 07 AMC
Avg Volume 673.89K
Price 40.94
SMA20 -6.41%
SMA50 -6.49%
SMA200 8.03%
Trades
Volume 249,095
Change -0.53%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-11-24 Upgrade
Stifel
Hold → Buy
$30 → $50
Dec-05-23 Downgrade
Needham
Buy → Hold
Dec-04-23 Initiated
Morgan Stanley
Equal-Weight
$35
Sep-15-23 Downgrade
The Benchmark Company
Buy → Hold
Aug-03-23 Downgrade
Canaccord Genuity
Buy → Hold
$77 → $48
Jun-07-23 Downgrade
William Blair
Outperform → Mkt Perform
Apr-17-23 Initiated
Piper Sandler
Neutral
$65
Feb-06-23 Downgrade
BTIG Research
Buy → Neutral
Dec-28-22 Reiterated
BTIG Research
Buy
$80 → $67
Dec-08-22 Initiated
Stifel
Hold
$60
Nov-07-22 Upgrade
Sidoti
Neutral → Buy
Oct-14-22 Resumed
Stephens
Overweight
$91
Oct-13-22 Initiated
Mizuho
Buy
$85
Apr-08-22 Initiated
Needham
Buy
$87
Mar-28-22 Upgrade
The Benchmark Company
Hold → Buy
$97
Mar-18-22 Upgrade
BTIG Research
Neutral → Buy
$98
Jul-09-21 Initiated
Oppenheimer
Perform
$150
Jan-19-21 Downgrade
The Benchmark Company
Buy → Hold
Oct-26-20 Downgrade
Sidoti
Buy → Neutral
Aug-31-20 Upgrade
Sidoti
Neutral → Buy
$58
Show Previous Ratings
May-13-24 11:06AM
May-08-24 11:06AM
10:17AM
07:59AM
03:43AM
11:54PM
Loading…
May-07-24 11:54PM
07:30PM
05:58PM
05:26PM
(Associated Press Finance)
04:03PM
04:01PM
May-06-24 09:16AM
May-01-24 07:00AM
Apr-29-24 07:00AM
Apr-25-24 03:43PM
(Investor's Business Daily)
09:15AM
Loading…
Apr-05-24 09:15AM
Apr-04-24 04:26PM
(Investor's Business Daily) +16.48%
03:54PM
07:00AM
Apr-02-24 07:00AM
Mar-26-24 11:45AM
Mar-20-24 04:22AM
Mar-18-24 07:00AM
Mar-12-24 10:30AM
07:00AM
Mar-06-24 07:00AM
Feb-28-24 10:58AM
Feb-27-24 02:00PM
Feb-26-24 05:30PM
04:39PM
(Associated Press Finance)
04:34PM
Loading…
04:34PM
04:01PM
Feb-19-24 07:00AM
Jan-27-24 01:03PM
Jan-23-24 07:00AM
Jan-12-24 06:49PM
Jan-08-24 07:00AM
Dec-17-23 12:35PM
Dec-05-23 03:16AM
Dec-04-23 04:05PM
Nov-15-23 07:00AM
Nov-02-23 05:50PM
09:23AM
(Thomson Reuters StreetEvents)
Nov-01-23 06:30PM
05:56PM
04:17PM
(Associated Press Finance)
04:01PM
Oct-31-23 04:40PM
Oct-18-23 04:05PM
Oct-17-23 07:00AM
Oct-13-23 06:30PM
Oct-10-23 10:51AM
Sep-19-23 11:51AM
Sep-15-23 09:32AM
Sep-14-23 12:53PM
07:00AM
Sep-08-23 11:38AM
Sep-07-23 05:00PM
Aug-18-23 10:40AM
Aug-17-23 06:48PM
Aug-09-23 07:00AM
Aug-07-23 07:00AM
05:00AM
Aug-03-23 07:18PM
Aug-02-23 05:25PM
04:21PM
04:01PM
Jul-19-23 07:00AM
Jun-21-23 08:00PM
Jun-13-23 08:00AM
May-26-23 06:00AM
May-17-23 10:10AM
May-09-23 01:48PM
May-04-23 07:00AM
May-03-23 05:35PM
04:29PM
04:01PM
Apr-27-23 10:02AM
Apr-26-23 08:00PM
10:02AM
Apr-23-23 08:25AM
Apr-19-23 07:00AM
Apr-07-23 11:44AM
Apr-04-23 06:00PM
Mar-29-23 06:00PM
07:00AM
Mar-23-23 06:00PM
Mar-15-23 05:50PM
Mar-13-23 08:48AM
Mar-09-23 05:25AM
Feb-23-23 05:12AM
Feb-21-23 05:15PM
04:01PM
Feb-13-23 05:50PM
Feb-07-23 07:00AM
Feb-03-23 05:50PM
01:58PM
09:00AM
Jan-31-23 09:25AM
Jan-25-23 06:00PM
STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems. Its products include refractive and cataract solutions through the Collamer brand. The company was founded in 1982 and is headquartered in Lake Forest, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
BROADWOOD PARTNERS, L.P. 10% Owner May 09 '24 Buy 42.56 1 43 10,768,431 May 13 06:00 PM WEISNER AIMEE S Director Mar 14 '24 Buy 38.11 1,750 66,692 10,864 Mar 14 05:23 PM Williams Patrick F. Chief Financial Officer Mar 07 '24 Option Exercise 0.00 2,614 0 45,475 Mar 11 06:06 AM BROADWOOD PARTNERS, L.P. 10% Owner Jan 08 '24 Buy 27.11 4,042 109,570 10,768,430 Jan 10 05:44 PM BROADWOOD PARTNERS, L.P. 10% Owner Jan 05 '24 Buy 28.48 156,734 4,463,231 10,764,388 Jan 05 07:07 PM BROADWOOD PARTNERS, L.P. 10% Owner Jan 04 '24 Buy 28.91 63,246 1,828,183 10,607,654 Jan 05 07:07 PM BROADWOOD PARTNERS, L.P. 10% Owner Jan 03 '24 Buy 28.93 6,573 190,144 10,544,408 Jan 05 07:07 PM Zhou Lilian Yansheng Director Dec 06 '23 Buy 30.74 850 26,129 2,327 Dec 06 04:11 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 30 '23 Buy 31.42 177,707 5,583,678 10,537,835 Nov 30 07:08 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 29 '23 Buy 31.39 160,300 5,031,358 10,360,128 Nov 30 07:08 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 28 '23 Buy 31.85 96,984 3,088,794 10,199,828 Nov 30 07:08 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 13 '23 Buy 33.04 507 16,749 10,102,844 Nov 14 07:13 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 10 '23 Buy 32.73 34,320 1,123,383 10,102,337 Nov 14 07:13 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 09 '23 Buy 33.09 140,000 4,632,581 10,068,017 Nov 09 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 08 '23 Buy 33.71 139,409 4,699,073 9,928,017 Nov 09 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 07 '23 Buy 34.03 9,731 331,127 9,788,608 Nov 09 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 06 '23 Buy 34.16 164,607 5,623,518 9,778,877 Nov 06 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 03 '23 Buy 36.06 520 18,753 9,614,270 Nov 06 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 02 '23 Buy 35.79 144,027 5,155,243 9,613,750 Nov 06 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Oct 06 '23 Buy 37.62 75,299 2,832,417 9,469,723 Oct 06 07:43 PM BROADWOOD PARTNERS, L.P. 10% Owner Oct 05 '23 Buy 37.92 97,474 3,696,399 9,394,424 Oct 06 07:43 PM BROADWOOD PARTNERS, L.P. 10% Owner Oct 04 '23 Buy 37.93 32,523 1,233,649 9,296,950 Oct 06 07:43 PM BROADWOOD PARTNERS, L.P. 10% Owner Sep 21 '23 Buy 39.62 154,814 6,133,467 9,264,427 Sep 21 08:31 PM Lin Elizabeth Yeu Director Sep 21 '23 Buy 40.00 2,500 100,000 2,855 Sep 22 07:18 PM BROADWOOD PARTNERS, L.P. 10% Owner Sep 20 '23 Buy 40.67 132,079 5,372,274 9,109,613 Sep 21 08:31 PM BROADWOOD PARTNERS, L.P. 10% Owner Sep 19 '23 Buy 40.89 4,490 183,613 8,977,534 Sep 21 08:31 PM BROADWOOD PARTNERS, L.P. 10% Owner Sep 07 '23 Buy 41.26 60,874 2,511,722 8,973,044 Sep 07 07:00 PM BROADWOOD PARTNERS, L.P. 10% Owner Sep 06 '23 Buy 41.43 108,944 4,513,735 8,912,170 Sep 07 07:00 PM BROADWOOD PARTNERS, L.P. 10% Owner Sep 05 '23 Buy 41.87 20,144 843,455 8,803,226 Sep 07 07:00 PM Williams Patrick F. Chief Financial Officer Aug 10 '23 Option Exercise 0.00 5,122 0 45,400 Aug 11 06:01 PM WEISNER AIMEE S Director Aug 07 '23 Buy 48.72 2,000 97,440 5,417 Aug 07 04:16 PM Kliman Gilbert H Director Jun 15 '23 Option Exercise 0.00 3,417 0 9,656 Jun 16 08:39 PM WEISNER AIMEE S Director Jun 15 '23 Option Exercise 0.00 3,417 0 3,417 Jun 16 08:37 PM Yu K Peony Director Jun 15 '23 Option Exercise 0.00 1,709 0 2,786 Jun 16 08:35 PM FARRELL STEPHEN C Director Jun 15 '23 Option Exercise 0.00 1,709 0 8,276 Jun 16 08:41 PM Williams Patrick F. Chief Financial Officer Jun 06 '23 Option Exercise 0.00 5,121 0 47,387 Jun 07 04:53 PM
Index -
P/E -
EPS (ttm) -1.13
Insider Own 21.73%
Shs Outstand 11.33M
Perf Week 11.66%
Market Cap 51.30M
Forward P/E -
EPS next Y -0.84
Insider Trans 0.00%
Shs Float 8.92M
Perf Month 38.89%
Income -12.27M
PEG -
EPS next Q -0.29
Inst Own 42.62%
Short Float 0.92%
Perf Quarter -9.09%
Sales 44.50M
P/S 1.15
EPS this Y 22.52%
Inst Trans -0.49%
Short Ratio 1.91
Perf Half Y 87.50%
Book/sh 2.79
P/B 1.61
EPS next Y 16.75%
ROA -20.78%
Short Interest 0.08M
Perf Year 39.32%
Cash/sh 1.57
P/C 2.86
EPS next 5Y -
ROE -28.86%
52W Range 1.80 - 5.30
Perf YTD 28.21%
Dividend Est. -
P/FCF -
EPS past 5Y 0.14%
ROI -26.00%
52W High -15.09%
Beta 0.62
Dividend TTM -
Quick Ratio 2.36
Sales past 5Y 12.81%
Gross Margin 47.99%
52W Low 150.00%
ATR (14) 0.33
Dividend Ex-Date -
Current Ratio 4.06
EPS Y/Y TTM 34.33%
Oper. Margin -24.09%
RSI (14) 74.12
Volatility 8.22% 8.78%
Employees 130
Debt/Eq 0.05
Sales Y/Y TTM 29.85%
Profit Margin -27.57%
Recom 1.00
Target Price 8.00
Option/Short Yes / Yes
LT Debt/Eq 0.04
EPS Q/Q 52.50%
Payout -
Rel Volume 0.61
Prev Close 4.19
Sales Surprise 0.36%
EPS Surprise 33.75%
Sales Q/Q 28.31%
Earnings May 09 BMO
Avg Volume 42.81K
Price 4.50
SMA20 21.89%
SMA50 28.37%
SMA200 35.46%
Trades
Volume 25,962
Change 7.40%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-24-21 Initiated
SVB Leerink
Outperform
$20
May-23-24 08:00AM
May-13-24 11:14AM
May-09-24 11:57AM
07:00AM
May-02-24 08:00AM
06:38PM
Loading…
May-01-24 06:38PM
Apr-01-24 06:28PM
Mar-05-24 09:11AM
Mar-04-24 07:00AM
Mar-01-24 05:01PM
Feb-26-24 08:00AM
Nov-12-23 09:38AM
Nov-09-23 07:00AM
Nov-02-23 08:03AM
Aug-09-23 07:00AM
07:00AM
Loading…
Jul-24-23 07:00AM
May-15-23 07:00AM
May-10-23 08:00AM
Mar-20-23 03:05AM
Mar-16-23 07:00AM
Mar-09-23 08:00AM
Feb-14-23 07:00AM
Nov-22-22 08:00AM
Nov-09-22 07:00AM
Nov-02-22 08:00AM
Sep-08-22 07:00AM
Aug-16-22 07:00AM
Aug-08-22 07:00AM
Aug-01-22 08:00AM
Jun-13-22 07:00AM
07:30AM
Loading…
Jun-09-22 07:30AM
May-09-22 07:00AM
May-02-22 08:00AM
Apr-21-22 09:08AM
Mar-03-22 07:00AM
Mar-01-22 07:00AM
Feb-28-22 04:01PM
Feb-23-22 02:01AM
Feb-10-22 08:00AM
Jan-04-22 08:00AM
Dec-31-21 07:53AM
Nov-16-21 08:00AM
Nov-12-21 07:00AM
Nov-08-21 07:00AM
Nov-01-21 08:00AM
Oct-02-21 10:32AM
Sep-02-21 08:00AM
Aug-16-21 08:00AM
Aug-05-21 07:00AM
Jul-29-21 08:00AM
Jul-15-21 08:00AM
May-24-21 08:00AM
May-05-21 07:00AM
06:45AM
Apr-28-21 08:00AM
Mar-10-21 07:00AM
Mar-03-21 04:05PM
Feb-16-21 01:28PM
Feb-08-21 08:00AM
Feb-01-21 07:00AM
Jan-03-21 03:58AM
Nov-23-20 08:00AM
Nov-11-20 04:01PM
Nov-09-20 04:01PM
Nov-02-20 08:00AM
LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. Its product offers automation and customization options for astigmatism treatment planning and other steps of the refractive cataract surgery procedure. The company was founded by Scott Addyman, Randy W. Frey, and Ronald R. Krueger in 2004 and is headquartered in Orlando, FL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Winer Gary M Director Nov 22 '23 Buy 2.10 300 630 53,345 Nov 27 07:30 PM Winer Gary M Director Nov 16 '23 Buy 2.12 1,000 2,125 53,045 Nov 17 06:18 PM Winer Gary M Director Nov 15 '23 Buy 2.15 500 1,075 52,045 Nov 17 06:18 PM Winer Gary M Director Nov 10 '23 Buy 2.13 1,000 2,135 51,545 Nov 14 07:31 PM Winer Gary M Director Aug 11 '23 Buy 3.60 705 2,538 50,545 Aug 14 07:01 PM Winer Gary M Director Aug 10 '23 Buy 3.66 1,000 3,660 49,840 Aug 14 07:01 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite